Robert A Stewart's Net Worth
$19.3 Million
Who is Robert A Stewart?
Robert A Stewart has an estimated net worth of $19.3 Million. This is based on reported shares across multiple companies, which include Amneal Pharmaceuticals, Inc., Actavis plc, WATSON PHARMACEUTICALS INC, and CorMedix Inc..
SEC CIK
Robert A Stewart's CIK is 0001476493
Past Insider Trading and Trends
2013 was Robert A Stewart's most active year for acquiring shares with 6 total transactions. Robert A Stewart's most active month to acquire stocks was the month of February. 2013 was Robert A Stewart's most active year for disposing of shares, totalling 9 transactions. Robert A Stewart's most active month to dispose stocks was the month of February. 2013 saw Robert A Stewart paying a total of $6,514,500.00 for 281,699 shares, this is the most they've acquired in one year. In 2013 Robert A Stewart cashed out on 332,165 shares for a total of $26,809,680.74, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $8.39
President and CEORobert A Stewart owns 78,668 units of Class A Common Stock which is worth $660,024.52. In the year 2018 Robert A Stewart filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +362.75% | 61.67K |
$13.44 | -$290,424.96 | 78.67K |
May 7
| |||
Form 4
|
∞
| 17K |
$11.92 | $202,640.00 | 17K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actavis plc No price found
Chief Operating OfficerRobert A Stewart owns 41,253 units of Ordinary Shares and 66,650 units of Ordinary Shares, par value $0.0001. In the year 2013 Robert A Stewart filed a total of 13 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.12% | -2.15K |
$163.58 | -$351,533.42 | 66.65K |
Dec 29
| |||
Form 4
| +22.04% | 12.43K |
—
|
—
| 68.8K |
Oct 26
| |||
Form 4
| +15.02% | 7.36K |
$237.68 | $1,749,800.16 | 56.37K |
Apr 3
| |||
Form 4
| -1.53% | -761.00 |
$245.63 | -$186,924.43 | 49.01K |
Mar 5
| |||
Form 4
| +3.26% | 1.57K |
$229.32 | $360,261.72 | 49.77K |
Feb 1
| |||
Form 4
| +7.98% | 3.56K |
$295.70 | -$296,882.80 | 48.2K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +8.20% | 3.38K |
$197.05 | $666,620.15 | 44.64K |
May 9
| |||
Form 4
| -16.24% | -8.00K |
$166.02 | -$1,328,160.00 | 41.25K |
Dec 9
| |||
Form 4
| -16.88% | -10.00K |
$164.44 | -$1,644,400.00 | 49.25K |
Nov 15
| |||
Form 4
| -16.84% | -12.00K |
$158.39 | -$1,900,680.00 | 59.25K |
Nov 11
| |||
Form 4
|
∞
| 71.25K |
—
|
—
| 71.25K |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
WATSON PHARMACEUTICALS INC No price found
Pres-Global OperationsRobert A Stewart owns 22,000 units of Common Stock (Restricted). Robert A Stewart used to own units in Common Stock, par value $0.0033 but no longer holds any shares there.acquired a total of 215,863 shares in WATSON PHARMACEUTICALS INC at a cost of $6,514,500.00, Robert also disposed a total of 230,427 shares of WATSON PHARMACEUTICALS INC equalling to $22,136,490.98.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -73.89K |
$115.43 |
—
|
0
|
Sep 30 - Oct 1
| |||
Form 4/A
| -16.46% | -14.56K |
$136.02 | -$1,980,998.19 | 73.89K |
Aug 2
| |||
Form 4
| -16.46% | -14.56K |
$136.02 | -$1,980,998.19 | 73.89K |
Aug 2
| |||
Form 4
| +22.31% | 16.14K |
—
|
—
| 88.45K |
Mar 6
| |||
Form 4
| -6.27% | -4.83K |
$85.54 | -$413,500.36 | 72.32K |
Mar 2
| |||
Form 4
| +23.23% | 14.54K |
—
|
—
| 77.15K |
Oct 31
| |||
Form 4
| +45.26% | 19.51K |
—
|
—
| 62.61K |
Mar 8
| |||
Form 4
| -3.67% | -1.64K |
$58.17 | -$95,398.80 | 43.1K |
Feb 24
| |||
Form 4
| -3.50% | -1.62K |
$64.52 | -$104,651.44 | 44.74K |
Nov 16
| |||
Form 4
| +44.89% | 14.37K |
—
|
—
| 46.37K |
Mar 2
| |||
Form 4
| +45.45% | 10K |
—
|
—
| 32K |
Feb 24
| |||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CorMedix Inc. (CRMD) Snapshot price: $5.67
InvestorRobert A Stewart owns 11,000 units of Common Stock which is worth $62,370.00. In the year 2023 Robert A Stewart acquired a total of 20,000 shares in CorMedix Inc. at a cost of $87,470.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4/A
| +1,000.00% | 10K |
$4.37 | $43,735.00 | 11K |
May 17
| |||
Form 4
| +1,000.00% | 10K |
$4.37 | $43,735.00 | 11K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||